Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
利用临床病理特征和pERK1/2免疫组化表达构建预测乳头状甲状腺癌中BRAFV600E和RAS突变状态的模型
期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11102803
Harahap, Agnes Stephanie; Subekti, Imam; Panigoro, Sonar Soni; Asmarinah; Lisnawati; Werdhani, Retno Asti; Agustina, Hasrayati; Khoirunnisa, Dina; Mutmainnah, Mutiah; Gultom, Fajar Lamhot; Assadyk, Abdillah Hasbi; Ham, Maria Francisca
肿瘤
IHC
肿瘤免疫
BRAF
MAPK/ERK
甲状腺癌
RAS
免疫/内分泌